The presence of BCL-2 family proteins, although significantly more strongly expressed in advanced MDSs, did not become an independent prognostic factor because of the correlation that occurred with the number of blasts and the type of MDS according to FAB. The gene discussed is BCL2; the disease is myelodysplastic syndrome.